UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market
UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market
Read moreMon, 13th Dec 2010 18:06
UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreIN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair
Read more(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced on Friday that the US Patent and Trademark office (USPTO) has completed its examination of its application titled 'phenotype profile of human retinal progenitor cells', and has issued a notification of allowance for the issue of a patent.
Read moreUK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce
Read moreIN BRIEF: ReNeuron Posts Encouraging Data On Eye Condition Treatment
Read moreIN BRIEF: ReNeuron Signs Exosome Research Collaboration With US Firm
Read more(Sharecast News) - Cell-based therapeutics company ReNeuron Group announced on Thursday that it has signed a new research evaluation agreement with a major United States biotechnology company, in connection with the use of its proprietary exosomes for the delivery of novel gene silencing therapeutics.
Read moreIN BRIEF: ReNeuron Gets Approval In US And UK For Expanded Drug Trial
Read moreUK TRADING UPDATE SUMMARY: Bagir Says Cash Insufficient To Carry On
Read morePositive hRPC Stem Cell Trial Data Prompts ReNeuron To Expand Study
Read moreData From ReNeuron CTX Stem Cell Therapy Trial Published In Journal
Read moreWoodford Transfers Series Of Holdings To New Manager Schroders
Read more(Sharecast News) - ReNeuron Group on Friday reported a narrower interim loss after receiving payment from a Chinese licensee, while it also made progress in its clinical and research programmes.
Read moreReNeuron Reports "Strong Progress" Across Various Programmes
Read more